FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.

The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.

U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry…